 TEL AVIV, Israel, March 30, 2021 GLOBE NEWSWIRE -- VBL Therapeutics Nasdaq: VBLT today announced that it will host a virtual RD Day for analysts and investors beginning at 10:00am ET on Tuesday, April 6, 2021. The event will include presentations from Professor Dror Harats, M.D, Chief Executive Officer, Dr. Bradley Monk, M.D., FACS, FACOG, Chair of the OVAL Study Steering Committee, and Dr. Tami Rachmilewitz, M.D, Vice President of Clinical Development, and will focus on the Companys clinical-stage pipeline including lead program, VB-111. The live event can be accessed at 